SCHEMBL6851114

SCHEMBL6851114

OCc1cnc(S)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13052871 0.76 — —
SCHEMBL13187443 0.73 — —
SCHEMBL216691 0.71 — —
SCHEMBL11481120 0.71 — —
SCHEMBL10563288 0.69 TAAR1 (0.50) —
SCHEMBL9425091 0.67 BRS3 (0.38) —
SCHEMBL12740605 0.67 PKM (0.34) —
SCHEMBL3903767 0.66 — —
SCHEMBL12458944 0.66 PKM (0.33) —
SCHEMBL16266065 0.64 PKM (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0146228-B1 SUBSTITUTED 2-MERCAPTO-IMIDAZOLES AND THEIR PREPARATION AND USE Farmos-Yhtyma Oy (FI) 1988-01-20 — — EP claimed
EP-3587411-B1 1-(ALPHA-METHYLBENZYL)-5-(PIPERIDINOMETHYL)IMIDAZOLE DERIVATIVES AND USES THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG MERCK SHARP & DOHME (US) 2021-01-27 — — EP disclosed
EP-3068390-B1 PIPERAZINE-IMIDAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG MERCK SHARP & DOHME (US) 2019-06-26 — — EP disclosed
EP-1397360-A1 AZAINDOLES Aventis Pharma Limited (GB) 2004-03-17 — — EP disclosed
EP-1294378-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2004-01-28 — — EP disclosed
US-6630593-B1 A process for preparing a 1-substituted 5-hydroxymethylimidazole of the formula: wherein R represents alkyl, hydroxyalkyl, allyl, or substituted or unsubstituted arylmethyl or diarylmethyl, comprising the step of reacting a LG CHEM INVESTMENT LTD. (KR) 2003-10-07 — — US disclosed
EP-1294378-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-26 — — EP disclosed
WO-2003000688-A1 AZAINDOLES AVENTIS PHARMA LIMITED (GB) 2003-01-03 — — WO disclosed
WO-2001089457-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-29 — — WO disclosed
Send feedback